A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients.

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has completed enrollment in the pivotal cohort (Cohort 1) of the global Phase 3 REVEAL study evaluating obudanersen (ION582), an ...

Before the advent of JAK inhibitors, we did not have any effective therapy for patients with myelofibrosis. We could offer ...

Kolkata: The Calcutta High Court on Wednesday frowned on the Bidhannagar Municipal Corporation (BMC) over allegations of ...

The ultra-sensitive test can find hidden signs of pancreatic cancer by looking for a key KRAS genetic mutation missed by ...

Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...

A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

Beneath the surface of soybean fields, an invisible threat is costing farmers billions. Now, researchers at the University of Missouri are uncovering how nature itself may hold the key to fighting ...

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

Dental enamel is the hardest substance in the human body, protecting teeth from wear, temperature changes, and decay. However, enamel cannot regenerate once damaged. Inherited disorders, such as ...